346 related articles for article (PubMed ID: 27126057)
1. Systemic and spinal administration of FAAH, MAGL inhibitors and dual FAAH/MAGL inhibitors produce antipruritic effect in mice.
Yesilyurt O; Cayirli M; Sakin YS; Seyrek M; Akar A; Dogrul A
Arch Dermatol Res; 2016 Jul; 308(5):335-45. PubMed ID: 27126057
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors.
Bedse G; Bluett RJ; Patrick TA; Romness NK; Gaulden AD; Kingsley PJ; Plath N; Marnett LJ; Patel S
Transl Psychiatry; 2018 Apr; 8(1):92. PubMed ID: 29695817
[TBL] [Abstract][Full Text] [Related]
3. The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents.
Sakin YS; Dogrul A; Ilkaya F; Seyrek M; Ulas UH; Gulsen M; Bagci S
Neurogastroenterol Motil; 2015 Jul; 27(7):936-44. PubMed ID: 25869205
[TBL] [Abstract][Full Text] [Related]
4. Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model.
Adamson Barnes NS; Mitchell VA; Kazantzis NP; Vaughan CW
Br J Pharmacol; 2016 Jan; 173(1):77-87. PubMed ID: 26398331
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
6. The effects of fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on lipopolysaccharide-induced airway inflammation in mice.
Abohalaka R; Bozkurt TE; Nemutlu E; Onder SC; Sahin-Erdemli I
Pulm Pharmacol Ther; 2020 Jun; 62():101920. PubMed ID: 32416152
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of serotonin-induced itch responses by inhibition of endocannabinoid degradative enzymes, fatty acid amide hydrolase and monoacylglycerol lipase.
Tosun NC; Gunduz O; Ulugol A
J Neural Transm (Vienna); 2015 Mar; 122(3):363-7. PubMed ID: 24915981
[TBL] [Abstract][Full Text] [Related]
8. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
[TBL] [Abstract][Full Text] [Related]
9. Dual inhibition of endocannabinoid catabolic enzymes produces enhanced antiwithdrawal effects in morphine-dependent mice.
Ramesh D; Gamage TF; Vanuytsel T; Owens RA; Abdullah RA; Niphakis MJ; Shea-Donohue T; Cravatt BF; Lichtman AH
Neuropsychopharmacology; 2013 May; 38(6):1039-49. PubMed ID: 23303065
[TBL] [Abstract][Full Text] [Related]
10. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.
Long JZ; Nomura DK; Vann RE; Walentiny DM; Booker L; Jin X; Burston JJ; Sim-Selley LJ; Lichtman AH; Wiley JL; Cravatt BF
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20270-5. PubMed ID: 19918051
[TBL] [Abstract][Full Text] [Related]
11. The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184.
Seillier A; Dominguez Aguilar D; Giuffrida A
Pharmacol Biochem Behav; 2014 Sep; 124():153-9. PubMed ID: 24911644
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice.
Gamage TF; Ignatowska-Jankowska BM; Muldoon PP; Cravatt BF; Damaj MI; Lichtman AH
Drug Alcohol Depend; 2015 Jan; 146():7-16. PubMed ID: 25479915
[TBL] [Abstract][Full Text] [Related]
13. Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice.
Ghosh S; Kinsey SG; Liu QS; Hruba L; McMahon LR; Grim TW; Merritt CR; Wise LE; Abdullah RA; Selley DE; Sim-Selley LJ; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2015 Aug; 354(2):111-20. PubMed ID: 25998048
[TBL] [Abstract][Full Text] [Related]
14. Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in Mice.
Owens RA; Ignatowska-Jankowska B; Mustafa M; Beardsley PM; Wiley JL; Jali A; Selley DE; Niphakis MJ; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2016 Aug; 358(2):306-14. PubMed ID: 27307500
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoid degradation inhibitors ameliorate neuronal and synaptic alterations following traumatic brain injury.
Fucich EA; Stielper ZF; Cancienne HL; Edwards S; Gilpin NW; Molina PE; Middleton JW
J Neurophysiol; 2020 Feb; 123(2):707-717. PubMed ID: 31913777
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
Walentiny DM; Vann RE; Wiley JL
Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
[TBL] [Abstract][Full Text] [Related]
17. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
Kinsey SG; Long JZ; O'Neal ST; Abdullah RA; Poklis JL; Boger DL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2009 Sep; 330(3):902-10. PubMed ID: 19502530
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
Spradley JM; Guindon J; Hohmann AG
Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
[TBL] [Abstract][Full Text] [Related]
19. Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model.
Anderson WB; Gould MJ; Torres RD; Mitchell VA; Vaughan CW
Neuropharmacology; 2014 Jun; 81():224-30. PubMed ID: 24384256
[TBL] [Abstract][Full Text] [Related]
20. Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice.
Wiebelhaus JM; Grim TW; Owens RA; Lazenka MF; Sim-Selley LJ; Abdullah RA; Niphakis MJ; Vann RE; Cravatt BF; Wiley JL; Negus SS; Lichtman AH
J Pharmacol Exp Ther; 2015 Feb; 352(2):195-207. PubMed ID: 25398241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
